Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes

Inhalation Toxicology

Volumn 24, Issue 12, 2012, Pages 831-838

  Frampton, Mark W ^a   Bausch, Jan ^a   Chalupa, David ^a   Hopke, Philip K ^b   Little, Erika L ^a   Oakes, David ^a   Stewart, Judith C ^a   Utell, Mark J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CLARKSON UNIVERSITY   (United States)

Author keywords

Air pollution; Diabetes; Platelet activation; Ultrafine particles

Indexed keywords

CD40 LIGAND; PADGEM PROTEIN;

ADULT; AIR POLLUTANT; AMBIENT AIR; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONJUGATE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHESIS; LEUKOCYTE; MALE; METEOROLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; ULTRAFINE PARTICLE;

ADULT; AIR POLLUTANTS; AIR POLLUTION; BIOLOGICAL MARKERS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CD40 LIGAND; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTICLE SIZE; PARTICULATE MATTER; PLATELET ACTIVATION; SOLUBILITY; SURFACE PROPERTIES; UP-REGULATION;

EID: 84867176530     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.724117     Document Type: Article

References (31)

1. Bhaskaran K, Hajat S, Armstrong B, Haines A, Herrett E, Wilkinson P, Smeeth L. 2011. The effects of hourly differences in air pollution on the risk of myocardial infarction: case crossover analysis of the MINAP database. BMJ 343:d5531.
2. Carlsten C, Kaufman JD, Peretz A, Trenga CA, Sheppard L, Sullivan JH. 2007. Coagulation markers in healthy human subjects exposed to diesel exhaust. Thromb Res 120:849-855. (Pubitemid 47422334)
3. Chalupa DC, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. 2004. Ultrafine particle deposition in subjects with asthma. Environ Health Perspect 112:879-882. (Pubitemid 38811931)
4. Daigle CC, Chalupa DC, Gibb FR, Morrow PE, Oberdorster G, Utell MJ, Frampton MW. 2003. Ultrafine particle deposition in humans during rest and exercise. Inhal Toxicol 15:539-552. (Pubitemid 36648204)
5. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen DL, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C. 2008. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect 116:898-906. (Pubitemid 351943897)
6. Frampton MW, Samet JM, Utell MJ. 2000. Cardiopulmonary consequences of particle inhalation. In: Particle-lung interactions. Gehr PJ, Heyder, eds. New York: Marcel Dekker, Inc., pp. 653-670.
7. Frampton MW, Stewart JC, Oberdorster G, Morrow PE, Chalupa D, Pietropaoli AP, Frasier LM, Speers DM, Cox C, Huang LS, Utell MJ. 2006. Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans. Environ Health Perspect 114:51-58. (Pubitemid 43056868)
8. Franchini M, Mannucci PM. 2011. Thrombogenicity and cardiovascular effects of ambient air pollution. Blood 118:2405-2412.
9. Goldberg MS, Burnett RT, Yale JF, Valois MF, Brook JR. 2006. Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease. Environ Res 100:255-267. (Pubitemid 43155278)
10. Jacobs L, Emmerechts J, Mathieu C, Hoylaerts MF, Fierens F, Hoet PH, Nemery B, Nawrot TS. 2010. Air pollution related prothrombotic changes in persons with diabetes. Environ Health Perspect 118:191-196.
11. Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, Behar JV, Hern SC, Engelmann WH. 2001. The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol 11:231-252. (Pubitemid 32701612)
12. Liao D, Heiss G, Chinchilli VM, Duan Y, Folsom AR, Lin HM, Salomaa V. 2005. Association of criteria pollutants with plasma hemostatic/ inflammatory markers: a population-based study. J Expo Anal Environ Epidemiol 15:319-328. (Pubitemid 41140905)
13. Linden MD, Frelinger AL 3rd, Barnard MR, Przyklenk K, Furman MI, Michelson AD. 2004. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30:501-511. (Pubitemid 39426383)
14. Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, Cassee FR, Donaldson K, Boon NA, Badimon JJ, Sandstrom T, Blomberg A, Newby DE. 2008. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J 29:3043-3051.
15. Michelson AD, Benoit SE, Kroll MH, Li JM, Rohrer MJ, Kestin AS, Barnard MR. 1994. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood 83:3562-3573. (Pubitemid 24175546)
16. Natarajan A, Zaman AG, Marshall SM. 2008. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diab Vasc Dis Res 5:138-144. (Pubitemid 351839287)
17. Nemmar A, Hoylaerts MF, Nemery B. 2006. Effects of particulate air pollution on hemostasis. Clin Occup Environ Med 5:865-881.
18. Peters A, Liu E, Verrier RL, Schwartz J, Gold DR, Mittleman M, Baliff J, Oh JA, Allen G, Monahan K, Dockery DW. 2000. Air pollution and incidence of cardiac arrhythmia. Epidemiology 11:11-17. (Pubitemid 30005145)
19. Peters A, von Klot S, Heier M, Trentinaglia I, Hormann A, Wichmann HE, Lowel H; Cooperative Health Research in the Region of Augsburg Study Group. 2004. Exposure to traffic and the onset of myocardial infarction. N Engl J Med 351:1721-1730. (Pubitemid 39383207)
20. Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71-77. (Pubitemid 38056024)
21. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882-893. (Pubitemid 41622255)
22. Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. 2012. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environ Health Perspect 120:1162-1169.
23. Ruckerl R, Phipps RP, Schneider A, Frampton M, Cyrys J, Oberdorster G, Wichmann HE, Peters A. 2007. Ultrafine particles and platelet activation in patients with coronary heart disease-results from a prospective panel study. Part Fibre Toxicol 4:1.
24. Samet JM, Rappold A, Graff D, Cascio WE, Berntsen JH, Huang YC, Herbst M, Bassett M, Montilla T, Hazucha MJ, Bromberg PA, Devlin RB. 2009. Concentrated ambient ultrafine particle exposure induces cardiac changes in young healthy volunteers. Am J Respir Crit Care Med 179:1034-1042.
25. Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. 1998. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79:885-896. (Pubitemid 28224718)
26. Schwartz J, Park SK, O'Neill MS, Vokonas PS, Sparrow D, Weiss S, Kelsey K. 2005. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am J Respir Crit Care Med 172:1529-1533. (Pubitemid 43076541)
27. Shah AP, Pietropaoli AP, Frasier LM, Speers DM, Chalupa DC, Delehanty JM, Huang LS, Utell MJ, Frampton MW. 2008. Effect of inhaled carbon ultrafine particles on reactive hyperemia in healthy human subjects. Environ Health Perspect 116:375-380. (Pubitemid 351395607)
28. Simak J, Gelderman MP. 2006. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20:1-26. (Pubitemid 41811224)
29. Stewart JC, Chalupa DC, Devlin RB, Frasier LM, Huang LS, Little EL, Lee SM, Phipps RP, Pietropaoli AP, Taubman MB, Utell MJ, Frampton MW. 2010. Vascular effects of ultrafine particles in persons with type 2 diabetes. Environ Health Perspect 118:1692-1698.
30. Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. 2002. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol 14:1231-1247. (Pubitemid 36019737)
31. Zanobetti A, Schwartz J. 2002. Cardiovascular damage by airborne particles: are diabetics more susceptible? Epidemiology 13:588-592.